A detailed history of Captrust Financial Advisors transactions in Becton Dickinson & CO stock. As of the latest transaction made, Captrust Financial Advisors holds 78,170 shares of BDX stock, worth $17.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
78,170
Previous 80,252 2.59%
Holding current value
$17.7 Million
Previous $18.8 Million 0.49%
% of portfolio
0.06%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$221.47 - $242.41 $461,100 - $504,697
-2,082 Reduced 2.59%
78,170 $18.8 Million
Q2 2024

Aug 14, 2024

SELL
$225.07 - $246.17 $286,063 - $312,882
-1,271 Reduced 1.56%
80,252 $18.8 Million
Q1 2024

May 15, 2024

SELL
$233.45 - $247.73 $3.99 Million - $4.24 Million
-17,103 Reduced 17.34%
81,523 $20.2 Million
Q4 2023

Feb 14, 2024

SELL
$232.24 - $267.23 $647,020 - $744,502
-2,786 Reduced 2.75%
98,626 $24 Million
Q3 2023

Nov 14, 2023

BUY
$254.9 - $283.59 $89,469 - $99,540
351 Added 0.35%
101,412 $26.2 Million
Q2 2023

Aug 14, 2023

BUY
$238.39 - $265.32 $3.79 Million - $4.22 Million
15,897 Added 18.67%
101,061 $26.7 Million
Q1 2023

May 15, 2023

SELL
$229.71 - $259.35 $1.58 Million - $1.79 Million
-6,899 Reduced 7.49%
85,164 $21.1 Million
Q4 2022

Feb 15, 2023

BUY
$218.29 - $256.91 $934,281 - $1.1 Million
4,280 Added 4.88%
92,063 $23.4 Million
Q3 2022

Nov 16, 2022

BUY
$51.03 - $264.23 $305,465 - $1.58 Million
5,986 Added 7.32%
87,783 $19.6 Million
Q2 2022

Aug 23, 2022

SELL
$234.74 - $275.42 $1.23 Million - $1.44 Million
-5,228 Reduced 6.01%
81,797 $20.2 Million
Q2 2022

Aug 16, 2022

BUY
$234.74 - $275.42 $4.08 Million - $4.79 Million
17,393 Added 24.98%
87,025 $21.5 Million
Q1 2022

May 16, 2022

SELL
$243.64 - $270.48 $153,493 - $170,402
-630 Reduced 0.9%
69,632 $18.5 Million
Q4 2021

Feb 14, 2022

SELL
$230.08 - $250.94 $25,308 - $27,603
-110 Reduced 0.16%
70,262 $17.7 Million
Q3 2021

Nov 16, 2021

BUY
$232.72 - $256.47 $310,913 - $342,643
1,336 Added 1.94%
70,372 $17.3 Million
Q2 2021

Aug 16, 2021

BUY
$232.65 - $254.58 $81,194 - $88,848
349 Added 0.51%
69,036 $16.8 Million
Q1 2021

May 17, 2021

BUY
$232.09 - $256.88 $246,247 - $272,549
1,061 Added 1.57%
68,687 $16.7 Million
Q4 2020

Feb 16, 2021

BUY
$221.92 - $245.94 $679,297 - $752,822
3,061 Added 4.74%
67,626 $16.9 Million
Q3 2020

Nov 17, 2020

SELL
$215.77 - $276.76 $1.43 Million - $1.83 Million
-6,616 Reduced 9.29%
64,565 $14.9 Million
Q2 2020

Aug 14, 2020

SELL
$219.9 - $263.41 $397,139 - $475,718
-1,806 Reduced 2.47%
71,181 $17.2 Million
Q1 2020

May 15, 2020

SELL
$195.69 - $279.01 $232,479 - $331,463
-1,188 Reduced 1.6%
72,987 $16.5 Million
Q4 2019

Feb 14, 2020

BUY
$236.45 - $266.82 $2.8 Million - $3.16 Million
11,844 Added 19.0%
74,175 $20.2 Million
Q3 2019

Nov 14, 2019

SELL
$230.58 - $256.08 $305,287 - $339,049
-1,324 Reduced 2.08%
62,331 $15.8 Million
Q2 2019

Aug 13, 2019

BUY
$217.4 - $246.08 $3.05 Million - $3.46 Million
14,051 Added 28.33%
63,655 $16 Million
Q1 2019

May 15, 2019

SELL
$206.05 - $248.17 $96,843 - $116,639
-470 Reduced 0.94%
49,604 $12.4 Million
Q4 2018

Feb 13, 2019

SELL
$204.73 - $257.93 $98,884 - $124,580
-483 Reduced 0.96%
50,074 $11.3 Million
Q3 2018

Nov 15, 2018

BUY
$233.07 - $256.0 $3.83 Million - $4.21 Million
16,454 Added 48.25%
50,557 $13.2 Million
Q2 2018

Aug 13, 2018

BUY
$208.1 - $233.85 $839,891 - $943,818
4,036 Added 13.42%
34,103 $8.17 Million
Q1 2018

May 15, 2018

SELL
$205.46 - $240.27 $413,180 - $483,182
-2,011 Reduced 6.27%
30,067 $6.41 Million
Q4 2017

Feb 14, 2018

BUY
$189.0 - $222.64 $6.06 Million - $7.14 Million
32,078
32,078 $6.87 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.7B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.